t-cell
Entity, reached from Hormuz.
- Evidence
- 133 documents · 43 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 1 Jan 2026, last seen 8 Oct 2026
- Measured
- 14% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- The ASCO Post · 2026-10-05 · Relapsed or Refractory SCLC Phase I Study of Novel CAR T-Cell Therapy (opens the source in a new tab)
- Pulse 2.0 · 2026-10-03 · Novartis Signs Up To $7.8 Billion Licensing Deal With Abogen For mRNA-Encoded T-Cell Engager (opens the source in a new tab)
- J Immunother Cancer · 2026-10-01 · Propionate promotes CD8+ T-cell infiltration and enhances immunotherapy efficacy in colorectal cancer. (opens the source in a new tab)
- bioRxiv Cancer Biology · 2026-09-28 · Spatial immune profiling reveals lymphocyte confinement to myeloid-mesenchymal niches and heterogeneous therapeutic T-cell opportunity in pediatric ependymoma (opens the source in a new tab)
- Br J Pharmacol · 2026-09-28 · Low-dose antiangiogenic multikinase inhibitor AL3810 synergizes with PD-1 blockade by reducing CSF1-driven MHC-IIint tumour-associated macrophages to optimize TIM-3+ CD8… (opens the source in a new tab)
- European Medical Journal · 2026-09-24 · Fatal Inflammatory Risks Associated with CAR T-Cell Therapy (opens the source in a new tab)
- BMJ Oncol · 2026-09-21 · Cytotoxic T-cell exhaustion analyses by in situ single-cell immunofluorescence in relation to colorectal cancer patient age, tissue bacteria and mortality. (opens the source in a new tab)
- J Immunother Cancer · 2026-09-12 · Epigenetic plus cytokine therapy induces stem-like CD8+ T-cell reservoirs and intratumoral immune niches to overcome anti-PD-1 resistance. (opens the source in a new tab)
What is claimed about it
- Single source: Reported by one source so far.
Situations it is named in
Who it moves with
- co-mentioned with immunotherapy (62 documents)seen together
- co-mentioned with studie (49 documents)seen together
- co-mentioned with car-t (48 documents)seen together
- co-mentioned with fda (44 documents)seen together
- co-mentioned with ai (39 documents)seen together
- co-mentioned with clinical trial (29 documents)seen together
- co-mentioned with car t-cell (27 documents)seen together
- co-mentioned with clinical trials (27 documents)seen together
- co-mentioned with united states (27 documents)seen together